Published in Cancer Weekly, April 11th, 2000
The results of the studies were presented at the recent International Academy of Cytology (IAC) Conference in Chicago, Illinois.
Three studies demonstrated the performance of the AutoCyte PREP. The first PREP study, an independent study by Dr. A. Verhest and colleagues, entitled "Comparison of the AutoCyte PREP with the Conventional Pap Smear in Cervical Cancer Screening," found that, "the routine use of cell suspension with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.